EIP Pharma

Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia
Endpoints
Tue, 11/10/20 - 11:02 am
Locus Biosciences
CARB-X
CRISPR
rUTIs
UTIs
bacteriophage
EIP Pharma
Vertex Pharmaceuticals
dementia
clinical trials
EIP bags cash to trial ex-Vertex drug in dementia, Huntington's
Fierce Biotech
Mon, 04/15/19 - 10:00 am
EIP Pharma
Alzheimer's disease
dementia
Huntington's disease
EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate
CP Wire
Wed, 05/16/18 - 09:13 am
EIP Pharma
Alzheimer's disease
neflamapimod
EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate
Wed, 05/16/18 - 07:55 am
EIP Pharma
Alzheimer's disease
neflamapimod